SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-121519
Filing Date
2014-03-28
Accepted
2014-03-28 16:31:56
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d667381d10k.htm 10-K 773189
2 EX-10.21 d667381dex1021.htm EX-10.21 107513
3 EX-23.1 d667381dex231.htm EX-23.1 1490
4 EX-31.1 d667381dex311.htm EX-31.1 8496
5 EX-32.1 d667381dex321.htm EX-32.1 3411
12 GRAPHIC g667381image1.jpg GRAPHIC 64695
  Complete submission text file 0001193125-14-121519.txt   5414629

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rxii-20131231.xml EX-101.INS 588975
7 XBRL TAXONOMY EXTENSION SCHEMA rxii-20131231.xsd EX-101.SCH 48245
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20131231_cal.xml EX-101.CAL 69986
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20131231_def.xml EX-101.DEF 217790
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20131231_lab.xml EX-101.LAB 448054
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20131231_pre.xml EX-101.PRE 319991
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36304 | Film No.: 14726185
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences